Slide 1: Half-Year Results 2026
2026 HALF-YEAR RESULTS Presentation for investors, analysts and media Basel, August 19, 2026
Slide 2: Disclaimer
DISCLAIMER This presentation contains forward-looking statements, including statements regarding the beliefs, expectations and assumptions of future results, performance or achievements of Straumann Group, that are based upon information available to Straumann Group as of the date such statements ar
Slide 3: Agenda
AGENDA 1 Performance overview Guillaume Daniellot 2 Financial performance Isabelle Wege 3 Strategy update Guillaume Daniellot 4 2026 outlook Guillaume Daniellot 5 Q&A Guillaume Daniellot & Isabelle Wege 3
Slide 4: Performance Overview
PERFORMANCE OVERVIEW – Guillaume Daniellot, Group CEO – 4
Slide 5: Strong first-half performance and confirmed outlook
STRONG FIRST-HALF PERFORMANCE AND CONFIRMED OUTLOOK Growth, market share gains and margin progress Revenue in Q2 2026 Q2 organic growth in 2026 EBIT margin at constant currency1 707.0 M 8.5% 26.9% CHF 1.4 bn revenue in H1 5.9% in CHF and Core EBIT margin 25.7% 7.8% organic growth in H1 or 2.3% in CH
Slide 6: Strong growth across regions with varied market dynamics
STRONG GROWTH ACROSS REGIONS WITH VARIED MARKET DYNAMICS NAM EMEA Regional % share of Q2 26 8.4% Q2 26 8.6% organic growth HY1 26 8.1% HY1 26 8.2% 42 %* 26 NAM 26 %* GROUP 17 LATAM Q2 26 8.5% Q2 25 9.3% 13 APAC 9 %* 23 %* HY1 26 7.8% HY1 25 10.2% 44 EMEA LATAM APAC Q2 26 11.8% Q2 26 7.4% HY1 26 15.4
Slide 7: Financial Performance
FINANCIAL PERFORMANCE – Isabelle wEge, Group CFO – 7
Slide 8: Gross profit margin at 70.5% on a high level
GROSS PROFIT MARGIN AT 70.5% ON A HIGH LEVEL Thanks to improved profitability despite tariffs and growth investments in %, rounded 0.2 1.5 72.0 71.9 -50 bps 0.4 71.0 -0.3 -1.1 70.5 -0.6 IFRS gross profit Non-core items FX effect CORE gross Productivity Tech upgrade Tariffs CORE gross Non-core items
Slide 9: Core EBIT margin increased to 25.7%
CORE EBIT MARGIN INCREASED TO 25.7% EBIT margin amounting to 26.9% at constant 2025 currency exchange rates in %, rounded 2.1 +90 bps 1.3 0.1 25.7 25.4 24.8 -0.3 24.4 -1.8 -0.5 IFRS EBIT Non-core items FX effect CORE EBIT Gross profit Efficiency gains Other CORE EBIT Non-core items IFRS EBIT margin
Slide 10: Core net result reached CHF 262 M
CORE NET RESULT1 REACHED CHF 262 M Core net result margin 19.0% in CHF million, rounded +15.7% 266 38 2 262 -3 -2 251 -11 226 -39 CORE Net FX effect CORE Net EBIT Financial result Associates result Income tax CORE Net Non-core items IFRS Net Profit HY 2025 Profit FY 2025 Profit HY 2026 Profit HY 202
Slide 11: Strong cash position
STRONG CASH POSITION in CHF million, rounded Free cash flow1 CAPEX CHF 169m (12.2% of net revenue) in HY 2026 CHF 74m (5.4% of net revenue) in HY 2026 -19.9% 239 -105 475 381 -228 Cash Net cash operating Net cash investing Net cash financing & FX on cash Cash 1 Jan 2026 30 Jun 2026 11 1 Continuing o
Slide 12: Capital allocation priority order drives investments
Capital allocation priority order drives investments 1 Reinvestment in the business to drive sustainable future growth 2 Strong balance sheet to accelerate strategic priorities and pursue M&A 3 maintaining and increasing dividends with earnings 12
Slide 13: Strategy Update
STRATEGY UPDATE – Guillaume Daniellot, Group CEO – 13
Slide 14: A large market with significant room to grow
A LARGE MARKET WITH SIGNIFICANT ROOM TO GROW CHF 20 BN Perform Transform Implantology Clear aligner MARKET Market size >35% CHF 6.1BN <5% CHF 4.9BN OPPORTUNITY Market share RegenerativeS Digital equipment 10%+ CHF 1.8BN <13% CHF 1.3BN CADCAM Prosthetics CHF 5.7BN 14 % MARKET <5% SHARE CONSISTENTLY G
Slide 15: Our growth playbook: product leadership × customer experience
OUR GROWTH PLAYBOOK: PRODUCT LEADERSHIP × CUSTOMER EXPERIENCE Sirios X3 intraoral scanner Straumann Iexcel implant system Clearcorrect scalloped trimline aligner Straumann FAST Molar Solution Straumann access cloud-based platform Innovation Digitalization drives product excellence enhances efficienc
Slide 16: Digital efficiency is driving market share gains
DIGITAL EFFICIENCY IS DRIVING MARKET SHARE GAINS Double digit Double digit Double digit scanners sold increase of active users growth in healing abutments IOS portfolio – multi branding & multi pricing Open-cloud based Straumann axs platform Straumann group product portfolio Hardware 3Shape Premium
Slide 17: Customer experience leadership drives practice efficiency
CUSTOMER EXPERIENCE LEADERSHIP DRIVES PRACTICE EFFICIENCY Appointment Appointment Appointment Fast molar Workflow Save one full patient appointment by scanning on the day of surgery* Place Fast Molar Scan Fast Molar Restore Traditional Workflow Place Remove Place Scan Remove Place Restore Healing Ab
Slide 18: AI-powered implant conversion drives practice growth
AI-POWERED IMPLANT CONVERSION DRIVES PRACTICE GROWTH FROM A 2D PHOTO TO A DYNAMIC 3D SIMULATION – INSTANTLY AT THE CHAIRSIDE • AI-enabled “YES” simulation visualizes outcomes for advanced implant cases • Builds patient confidence and supports case conversion • Connected to Straumann AXS for efficien
Slide 19: Innovation and digital workflows extend premium growth
INNOVATION AND DIGITAL WORKFLOWS EXTEND PREMIUM GROWTH DRIVING PREMIUM LEADERSHIP • iEXCEL drives conversions, new account wins and share gains across key geographies, representing close to 40% of Straumann premium implant volumes • iGuide connects digital planning with guided implant treatment, imp
Slide 20: Investing in challenger expansion
INVESTING IN CHALLENGER EXPANSION Neodent continues to scale globally through further investments into: • Go-to-market capabilities in key geographies global • Education to accelerate customer adoption • Capacity expansion in Curitiba Medentika builds on its leading MPS abutment system, compatible w
Slide 21: China remains a large, underpenetrated implant market
CHINA REMAINS A LARGE, UNDERPENETRATED IMPLANT MARKET Global implant penetration per 10’000 adult inhabitants Benchmark «Implant penetration in China remains well below mature-market levels, 480 creating substantial headroom for long-term volume growth.» South Korea Spain Italy France Brazil Germany
Slide 22: Our global growth playbook, adapted to win in China
OUR GLOBAL GROWTH PLAYBOOK, ADAPTED TO WIN IN CHINA Our winning strategy in China • Multi-brand, multi-price-point portfolio Serving distinct customer needs from premium to challenger • Local manufacturing lower cost base, better supply resilience • Local partners and education Broader market access
Slide 23: ClearCorrect transformation progressing fast
CLEARCORRECT TRANSFORMATION PROGRESSING FAST New ClearCorrect value proposition gaining traction with customers • New digital features are driving strong GP adoption, accelerating active case growth and supporting market share gains • AI-enabled tools, especially Case Assessment, help GPs treat more
Slide 24: Ongoing investments to fuel future growth
ONGOING INVESTMENTS TO FUEL FUTURE GROWTH Operations & Innovation & Digital People & Go-To-Market Transformation Culture Initiatives 24 CONFIDENTIAL/INTERNAL USE ONLY
Slide 25: 2026 Outlook
2026 OUTLOOK – Guillaume Daniellot, Group CEO – 25
Slide 26: Upgraded outlook 2026 – confirmed
UPGRADED OUTLOOK 2026 – CONFIRMED 1 Significant growth opportunities in a CHF 20bn+ • High-single digit organic revenue addressable market with strong fundamentals growth Proven business model with strong market • 140 to 170 basis points positions amid continued volatility improvement of the cor
Slide 27: Any questions?
ANY QUESTIONS? 27
Slide 28: Calendar of upcoming events
CALENDAR OF UPCOMING EVENT 2026 Event Location 20-21 Aug Octavian Roadshow Zurich & Geneva 1 Sep Octavian HC Field Trip Basel 2-3 Sep Bernstein Roadshow Copenhagen & Stockholm 2 Sep BNP Paribas Bus Tour Basel 9 Sep Goldman Sachs European MedTech Conference London 22-23 Sep Bank of America Global Hea
Slide 29: Thank you.
THANK YOU. 29
Slide 30: Revenue development half-year 2026
REVENUE DEVELOPMENT HALF-YEAR 2026 (in CHF million, rounded) +2,3% +7,8% Organic 17 1.379 Regional % share of organic growth 13 1.348 26 26 NAM 44 17 LATAM 1.279 13 APAC 0 -69 Change in organic growth 44 EMEA +8.2% +8.1% +4.2% +15.4% Revenue FX effect M&A effect Adjusted EMEA NAM APAC LATAM Revenue
Slide 31: Core results reconciliation
CORE RESULTS RECONCILIATION H1, 2026 Pension plan (in CHF 1 000) IFRS M&A Impairments Legal cases settlements Other CORE Revenue 1 379 469 1 379 469 Cost of goods sold (386 854) 60 (20 816) (407 611) Gross profit 992 615 60 (20 816) 971 858 Other income 8 194 8 194 Distribution expense (268 111) 2 9
Slide 32: Half-year 2026 core financials at a glance
HALF-YEAR 2026 CORE FINANCIALS AT A GLANCE Core net profit at 19.0% HY 20261 % of Revenue Change in % CER2 Margin Change CER2 REVENUE 1 379 +7.8% COGS -408 29.5% GROSS PROFIT 972 70.5% +6.9% -50 bps Operating expenses -625 45.3% Other Result 8 0.6% EBIT 355 25.7% +11.9% +95 bps EBIT Margin at 20253
Slide 33: Half-year 2026 IFRS financials at a glance
HALF-YEAR 2026 IFRS FINANCIALS AT A GLANCE IFRS net profit at 18.2% HY 20261 % of Revenue Change in % CER2 Margin Change CER2 REVENUE 1 379 +7.8% COGS -387 28.0% GROSS PROFIT 993 72.0% +9.6% +118bps Operating expenses -650 47.1% Other Result 8 0.6% EBIT 351 25.4% +21.3% +282 bps Financial result -31
Slide 34: Currency exposure
CURRENCY EXPOSURE Revenue breakdown H1 2026 Exchange rates development 2024 – 2026 110.00 CHF Other 2% 21% EUR 100.00 26% BRL 90.00 7% CNY 80.00 16% USD/CAD/AUD 29% 70.00 06/2024 09/2024 12/2024 03/2025 06/2025 Total cost breakdown H1 2026 USDCHF EURCHF CNYCHF BRLCHF Other CHF 12% 21% FX sensitivity